logo
Plus   Neg
Share
Email

Eli Lilly Announces FDA Approval Of CYRAMZA For New Indication - Quick Facts

Eli Lilly and Company (LLY) announced the FDA has approved CYRAMZA for the treatment of patients with hepatocellular carcinoma who have a high alpha-fetoprotein and have been treated with sorafenib. As a result of the approval of the new indication, FDA has removed the boxed warning from the labeling of CYRAMZA. With the latest approval, the company has now received five FDA approvals for CYRAMZA.

Eli Lilly noted that it has filed applications for marketing authorization in the European Union and Japan for CYRAMZA and regulatory action is expected in mid-2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Cannabis company Curaleaf Holdings Inc. has agreed to acquire privately-held GR Companies, Inc. or Grassroots, for about $875 million in cash and stock. The acquisition will make Wakefield, Massachusetts-based Curaleaf the world's largest cannabis company by revenue and the largest in the U.S. by other key operating metrics. It will also expand Curaleaf's presence to 19 states. Auto giant General Motors' (GM) Chevrolet unveiled its new stunning Corvette Stingray 2020. Stingray 2020, the eighth generation of the Chevrolet Corvette, has received the biggest change since its initial launch in 1953. The new 2020 Corvette is a mid-engine vehicle, which is its engine is behind... Amazon.com's Prime Day has brought a smile to the face of some photographers who may have grabbed their best deals of their lives. The e-commerce giant accidentally discounted a wide range of premium camera gear for Prime Day earlier this week, which may have proved costly for it. Thanks to a pricing error, some lucky customers were able to buy premium camera gear bundles for below $100.
Follow RTT